Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 5 August 2019. John Milad.

Executive Summary

The latest salvo to improve kidney care in the US is a recent executive order from the Trump administration, with one of the key goals being to raise the percentage of dialysis patients on home dialysis to 80% by 2025 from 12% today. See what John Milad, CEO of UK-based Quanta Dialysis Technologies, said about it here.

“We strongly welcome the Trump administration’s commitment to early detection and treatment of chronic kidney disease (CKD) and to have up to 80% of new patients receiving home dialysis or a transplant by 2025.” – John Milad, CEO, Quanta Dialysis Technologies Ltd.

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT125456

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel